Why Heron Therapeutics (HRTX) Stock Is Rising Today – Heron…
Heron Therapeutics Inc HRTX has submitted a Supplemental Marketing Authorization Application for Zynrelef (bupivacaine and meloxicam) as a prolonged-release solution to support the proposed indication